Narcan (Anhydrous Naloxone Hydrochloride)

Naloxone, the active ingredient in Narcan, is an opioid antagonist presented as a sterile solution for intramuscular, intravenous, or subcutaneous use. It rapidly reverses the effects of opioid overdose in emergency situations and is used in both pre‑hospital and hospital settings.

GNH USA supplies Narcan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naloxone is an opioid antagonist used to treat conditions related to opioid exposure. - Opioid overdose: rapid reversal of life‑threatening respiratory depression. - Opioid‑induced sedation: restores consciousness and normal breathing. - Opioid toxicity in emergency settings: counteracts the pharmacologic effects of opioid agonists.

Naloxone may cause a range of adverse reactions following administration.

Common Side Effects: - Injection site pain or irritation. - Nausea or vomiting. - Sweating or diaphoresis. - Tachycardia. - Hypertension. - Restlessness or agitation.

Serious or Rare Side Effects: - Seizures. - Cardiac arrhythmias. - Pulmonary edema. - Severe hypotension. - Allergic reactions including rash. - Anaphylaxis.

Naloxone should be administered with careful clinical monitoring. - Assess airway and breathing before use: ensure patient can maintain ventilation. - Monitor vital signs after dosing: watch for rapid changes in blood pressure or heart rate. - Avoid use in patients with known hypersensitivity to naloxone or its excipients. - Consider reduced effectiveness in chronic opioid users due to tolerance. - Do not exceed recommended dosing without medical supervision. - Store at ambient temperature: keep in original packaging, protect from light and moisture.

Naloxone may interact with other medications that affect the central nervous system or cardiovascular function.

Major Interactions (Avoid): - Concurrent use of potent opioid agonists may diminish reversal effectiveness. - Use with mixed agonist‑antagonist opioids (e.g., buprenorphine) can precipitate severe withdrawal. - Co‑administration with drugs that lower seizure threshold may increase seizure risk.

Moderate Interactions (Monitor Closely): - Benzodiazepines may require additional respiratory support after naloxone. - Adrenergic agents can augment cardiovascular responses. - Antihypertensive medications may alter blood pressure responses post‑administration.